BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/13/2021 8:37:10 AM | Browse: 617 | Download: 1608
 |
Received |
|
2021-02-25 03:02 |
 |
Peer-Review Started |
|
2021-02-25 03:05 |
 |
First Decision by Editorial Office Director |
|
2021-06-23 14:24 |
 |
Return for Revision |
|
2021-06-23 14:24 |
 |
Revised |
|
2021-07-28 00:22 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2021-08-30 03:28 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2021-08-30 07:29 |
 |
Articles in Press |
|
2021-08-30 07:29 |
 |
Edit the Manuscript by Language Editor |
|
2021-09-12 02:58 |
 |
Typeset the Manuscript |
|
2021-10-11 04:19 |
 |
Publish the Manuscript Online |
|
2021-10-13 08:37 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Minireviews |
| Article Title |
Tale of two kinases: Protein kinase A and Ca2+/calmodulin-dependent protein kinase II in pre-diabetic cardiomyopathy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Pamela Gaitán-González, Rommel Sánchez-Hernández, José-Antonio Arias-Montaño and Angélica Rueda |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| SEP-Cinvestav Project |
FIDSC 2018/2 |
| SEP-Conacyt Ciencia Básica 2017-2018 |
A1-S-9082 |
|
| Corresponding Author |
Angélica Rueda, PhD, Professor, Department of Biochemistry, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Av. IPN 2508, San Pedro Zacatenco, Ciudad de México 07360, Mexico. arueda@cinvestav.mx |
| Key Words |
Ca2+/calmodulin-dependent protein kinase II; Protein kinase A; Metabolic syndrome; Pre-diabetes; Pre-diabetic cardiomyopathy; β-Adrenoceptors |
| Core Tip |
Metabolic syndrome affects heart function leading to pre-diabetic cardiomyopathy. In an attempt to overcome contractility dysfunction, the activity of the sympathetic nervous system increases, but chronic stimulation of β-adrenoceptors leads to alterations in both protein kinase A (PKA) and Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity, the main effectors of the β-adrenergic response. This work recapitulates current evidence about the participation of PKA and CaMKII in experimental pre-diabetic cardiomyopathy, emphasizing the prevailing role of CaMKII in the development of cardiomyocyte Ca2+ mishandling and myocardial dysfunction associated with pre-diabetes. |
| Publish Date |
2021-10-13 08:37 |
| Citation |
Gaitán-González P, Sánchez-Hernández R, Arias-Montaño JA, Rueda A. Tale of two kinases: Protein kinase A and Ca2+/calmodulin-dependent protein kinase II in pre-diabetic cardiomyopathy. World J Diabetes 2021; 12(10): 1704-1718 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i10/1704.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i10.1704 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.